Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Higher antigliadin antibody levels are linked to alopecia areata severity.

The reply suggests checking for false positive or asymptomatic syphilis and using penicillin for treatment if necessary.

A woman poisoned with thallium was successfully treated with activated charcoal and Prussian blue.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

Spironolactone plus finasteride reduces hirsutism more effectively.

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Consider THPP in patients with muscle weakness and low potassium, as it is often underdiagnosed.

Triamcinolone can regrow hair in alopecia areata, but the effect is temporary.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Some people have severe allergic reactions to anthelminthic drugs, but these are often due to the parasites, not the drugs.

The scalp care solution with Timosaponin B-II improved scalp hydration, reduced dandruff, and helped prevent hair loss.

Autoimmune polyglandular syndrome can cause temporary brain issues that may improve on their own.

Hidradenitis suppurativa improves with antiandrogen therapy.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Thiosulfate may help hair grow faster in mice and works well with a common hair growth treatment.

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Antibodies help identify glycoproteins in normal skin and tumor cells.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

TNF-a may not be as involved in certain types of hair loss as previously thought.

Spironolactone and clascoterone are promising acne treatments with fewer side effects.

ANA-negative lupus nephritis can be diagnosed and treated effectively with a comprehensive approach.

Both cyproterone acetate and spironolactone effectively reduce hair growth in women with hirsutism.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Spironolactone is effective and safe for treating excessive facial hair in women.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.